| 1294 |
1181: Activation, Estrogen receptor |
1191: Increased, Non-genomic signaling |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1307 |
1181: Activation, Estrogen receptor |
1242: Increased, Second Messenger Production |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1103 |
1065: Activation, estrogen receptor alpha |
1066: Promotion, SIX-1 postive basal-type progenitor cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2665 |
1065: Activation, estrogen receptor alpha |
1985: Increased, Kisspeptin signalling |
Jun 6, 2022 |
Aug 15, 2022 |
1 AOP
|
| 2666 |
1065: Activation, estrogen receptor alpha |
1986: Decreased, Gonadotropins |
Jun 6, 2022 |
Aug 15, 2022 |
1 AOP
|
| 2730 |
1065: Activation, estrogen receptor alpha |
1991: Impaired, Reproduction |
Aug 15, 2022 |
Aug 15, 2022 |
1 AOP
|
| 2969 |
1065: Activation, estrogen receptor alpha |
2152: Epigenetic modification process |
Jul 27, 2023 |
Jul 27, 2023 |
1 AOP
|
| 133 |
116: Activation, FAS |
89: Synthesis, De Novo Fatty Acid (FA) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1422 |
116: Activation, FAS |
1306: Increased, lipogenesis |
Apr 13, 2017 |
Apr 13, 2017 |
None
|
| 1381 |
1293: Activation, FOXO |
1294: Inhibition, Wnt pathway |
Feb 15, 2017 |
Feb 15, 2017 |
1 AOP
|
| 1407 |
1304: Activation, FXR |
480: Activation, SHP |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 1408 |
1304: Activation, FXR |
227: Activation, PPARα |
Apr 12, 2017 |
Apr 12, 2017 |
None
|
| 385 |
122: Activation, Glucocorticoid Receptor |
145: Induction, IKB inhibitory protein |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1451 |
122: Activation, Glucocorticoid Receptor |
1335: Reduced, BDNF |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 2039 |
122: Activation, Glucocorticoid Receptor |
860: Decreased, Mitochondrial Fatty Acid Beta Oxidation |
Feb 22, 2020 |
Feb 22, 2020 |
None
|
| 2041 |
122: Activation, Glucocorticoid Receptor |
231: Decreased, PPAR-alpha activation |
Feb 22, 2020 |
Feb 22, 2020 |
None
|
| 2077 |
122: Activation, Glucocorticoid Receptor |
1759: Increase, Cripto-1 expression |
Apr 20, 2020 |
Jul 10, 2020 |
1 AOP
|
| 2261 |
122: Activation, Glucocorticoid Receptor |
54: Up Regulation, CD36 |
Jan 15, 2021 |
Jan 15, 2021 |
None
|
| 2266 |
122: Activation, Glucocorticoid Receptor |
1834: Decrease, ACAD |
Jan 15, 2021 |
Jan 15, 2021 |
1 AOP
|
| 752 |
760: Activation, Glutamate-gated chloride channel |
761: Increased, Chloride conductance |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1057 |
1018: Activation, Glutamate-gated chloride channels |
761: Increased, Chloride conductance |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 3084 |
1018: Activation, Glutamate-gated chloride channels |
388: Overactivation, NMDARs |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3085 |
1018: Activation, Glutamate-gated chloride channels |
2195: Increase, CNS Neural cell death |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 1204 |
1157: Activation, Hepatic nuclear receptor(s) |
1158: Increased, Hepatic thyroid hormone uptake/transport |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1205 |
1157: Activation, Hepatic nuclear receptor(s) |
295: Induction, Upregulation of glucuronyltransferase activity |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|